Rubaiya Anika | Health | Innovative Research Award

Innovative Research Award

Rubaiya Anika
Mount Sinai Hospital, United States

Rubaiya Anika
Affiliation Mount Sinai Hospital
Country United States
Documents 1
Subject Area Health
Event International Research Hypothesis Excellence Award
ORCID 0009-0005-9072-732X

Rubaiya Anika is a researcher affiliated with Mount Sinai Hospital in the United States whose documented research contribution addresses environmental exposure and biological aging. Her listed journal article examines urinary organophosphate metabolites in relation to laboratory-derived phenotypic aging acceleration among U.S. adults using data from the National Health and Nutrition Examination Survey (NHANES) covering 1999–2018. The work was published in the International Journal of Environmental Research and Public Health in August 2026 and provides a research contribution at the intersection of environmental health, exposure science, epidemiology, and aging research. [1]

Abstract

The research contribution associated with Rubaiya Anika investigates the relationship between urinary organophosphate metabolites and laboratory-derived phenotypic aging acceleration in U.S. adults. The study, titled Urinary Organophosphate Metabolites and Laboratory-Derived Phenotypic Aging Acceleration in U.S. Adults: Evidence from NHANES 1999–2018, uses population-based NHANES data to examine an environmental exposure question within an aging-related epidemiological framework. The article was published in the International Journal of Environmental Research and Public Health in August 2026 and is identified by DOI 10.3390/ijerph23091126. [1]

Keywords

  • Innovative Research Award
  • Rubaiya Anika
  • Organophosphate metabolites
  • Phenotypic aging
  • Environmental health

Introduction

Environmental exposures are an important area of public-health research because chemical exposures may vary across populations and may be investigated in relation to measurable biological and health outcomes. Organophosphate metabolites measured in urine can serve as biomarkers of exposure to organophosphate compounds, while phenotypic measures of aging can provide quantitative indicators for studying biological aging in epidemiological populations. The reported study brings these concepts together by analyzing nationally collected U.S. health data across multiple NHANES cycles from 1999 through 2018. [1]

Research Profile

Rubaiya Anika is identified in the supplied publication record as an author affiliated with Mount Sinai Hospital, United States. The documented subject area is Health, with the research contribution positioned within environmental and population health. The available publication record contains one indexed document supplied for this recognition profile.[1]

Research Contributions

The principal documented contribution is the study of urinary organophosphate metabolites in relation to laboratory-derived phenotypic aging acceleration. This research connects environmental exposure assessment with an aging-related outcome and uses nationally collected health-survey data as its analytical foundation. [1]

  • Evaluation of urinary organophosphate metabolite measurements as indicators of environmental exposure.
  • Investigation of phenotypic aging acceleration as a measurable aging-related outcome.
  • Use of NHANES data spanning 1999–2018 to support population-based analysis.
  • Integration of environmental epidemiology and biological aging research.[1]

Publications

The available record identifies one journal article associated with Rubaiya Anika:

Urinary Organophosphate Metabolites and Laboratory-Derived Phenotypic Aging Acceleration in U.S. Adults: Evidence from NHANES 1999–2018

The publication lists Rubaiya Anika, Matthew Untalan, Emanuela Taioli, and Stephanie Tuminello as contributors. The DOI provides a persistent identifier for the journal article and supports direct access to its bibliographic record. [1]

Research Impact

The documented research has potential relevance to environmental and population health because it investigates whether measurable environmental exposure biomarkers are associated with an aging-related phenotype in adults. Research of this type can contribute to hypothesis generation, exposure surveillance, and the identification of questions that may warrant further investigation through longitudinal, mechanistic, or experimental studies. [1]

Award Suitability

The documented publication provides a substantive basis for considering Rubaiya Anika for recognition under an Innovative Research Award framework. The work applies an interdisciplinary research approach by connecting environmental exposure biomarkers with a quantitative indicator of phenotypic aging in a U.S. adult population. [1]

  • Research innovation: The study links environmental exposure assessment with laboratory-derived phenotypic aging measures.
  • Interdisciplinary relevance: The research spans environmental health, epidemiology, exposure science, and aging research.
  • Population relevance: NHANES provides a nationally collected U.S. population dataset for epidemiological investigation.
  • Research communication: The work is documented through a peer-reviewed journal publication with a persistent DOI.
  • Future research value: The findings can help motivate additional research into environmental determinants of biological aging.

Conclusion

Rubaiya Anika’s documented research contribution focuses on the relationship between urinary organophosphate metabolites and laboratory-derived phenotypic aging acceleration among U.S. adults using NHANES data from 1999–2018. The resulting publication demonstrates an interdisciplinary approach to environmental and population health research and provides a basis for further investigation of environmental influences on aging-related outcomes. [1]

References

  1. Anika, R., Untalan, M., Taioli, E., & Tuminello, S. (2026). Urinary Organophosphate Metabolites and Laboratory-Derived Phenotypic Aging Acceleration in U.S. Adults: Evidence from NHANES 1999–2018. International Journal of Environmental Research and Public Health, 23(9), 1126.
    https://doi.org/10.3390/ijerph23091126

Yasser Khazaal | Medicine and Health Sciences | Best Researcher Award

Yasser Khazaal | Medicine and Health Sciences | Best Researcher Award

Prof. Dr Yasser Khazaal, Lausanne university, Switzerland

Prof. Dr. Yasser Khazaal is a distinguished psychiatrist and researcher with extensive experience in addiction psychiatry. He earned his MD from René Descartes, Paris V, and Swiss Board Certification in Psychiatry and Psychotherapy. Currently, he is a Full Professor at the University of Lausanne, Switzerland, and holds multiple roles including Associate Researcher at Montreal University. Prof. Khazaal’s research focuses on cognitive behavioral therapies, game-based interventions, and the development of smartphone apps for addiction treatment. He has published extensively on addictive disorders and is a key figure in international psychiatric societies. 🏥📚🔬

Publication Profile

google scholar

Education

Prof. Dr. Yasser Khazaal is a distinguished psychiatrist with an impressive academic background. He earned his MD from René Descartes, Paris V, France, in 1998. In 2005, he achieved Swiss Board Certification in Psychiatry and Psychotherapy. His expertise and contributions were further recognized with his appointment as a Privat Docent (senior lecturer) at Geneva University in 2009. Dr. Khazaal is known for his work in psychiatry and psychotherapy, holding a prominent position in the academic and clinical communities in Switzerland. 🌐🩺📚

Employment History

Prof. Dr. Yasser Khazaal has an extensive background in addiction psychiatry. From 2003 to 2005, he served as a senior psychiatrist and head of the mood and anxiety disorders outpatient unit at Lausanne University Hospital. From 2007 to 2018, he was the deputy head of the Addiction clinic at Geneva University Hospitals. Over the years, he held successive academic appointments at Geneva University, Switzerland, eventually becoming a full professor of addiction psychiatry at the Faculty of Biology and Medicine, University of Lausanne since 2019. He is also a member of the board of Addiction medicine at Lausanne University Hospital. Prof. Khazaal is an associate researcher at the Montreal University Institute of Mental Health, Canada, and an associate professor at the Department of Psychiatry and Addiction, Montreal University, Canada. Additionally, he served as a visiting professor at Kazimierz Wielki University, Poland, in 2022, as part of a project co-financed by the European Union. 📘🔍🌍

Teaching

Prof. Dr. Yasser Khazaal has extensive experience in teaching medical students at both the University of Lausanne (2003-2007, 2019-2023) and the University of Geneva (2007-2018). His teaching portfolio includes courses on mood and anxiety disorders (2003-2007), psychopharmacology (2006-2007), addiction (2019-2023), and community research in practice (2021-2023). He has also taught and supervised clinical cognitive and behavior therapy (CBT) skills (2018-2023), CBT for bipolar disorder (2007), CBT for mood disorders (2005-2006), and CBT of impulsive behaviors (2020). Prof. Dr. Khazaal is committed to integrating clinical teaching and practice in his courses. 📚💬🧠

Grants 

Prof. Dr. Yasser Khazaal is a leading researcher in addiction and mental health, with extensive funding from various Swiss and international sources. His projects include studies on cognitive behavioral interventions for psychosis, mood and anxiety disorders, smoking cessation, and smartphone applications for addiction treatment. Key grants include the Swiss National Science Foundation (268,426 CHF) and Astra-Zeneca (140,000 CHF) for LACOSMA, as well as research on “Impact of Pick Klop game on smoking cessation” (172,500 CHF) and smartphone applications (194,942 CHF). He collaborates internationally on projects such as managing trauma exposure in Congo (12,125 Euros) and the “Sesame” serious game for mental health (20,000 CHF). His work continues to advance the field with a focus on innovative and practical solutions to addiction and mental health challenges. 🧠💊🚬

Conferences and Awards

Prof. Dr. Yasser Khazaal is a distinguished academic and leader in the field of social psychiatry. He served as the Chair for the European Congress of Social Psychiatry in 2012, 2015, and 2018. He was also the Co-chair for the International Conference of Behavioral Addictions in 2016, held in Geneva, Switzerland. More recently, he co-chaired the Challenges of Ecology Related to Mental Health conference in Athens in 2022. In recognition of his contributions, he was elected an Honorary Fellow of the World Association of Social Psychiatry in 2013. 🌍🔍💬

Scientific Achievements

Prof. Dr. Yasser Khazaal is a renowned expert in addiction studies, focusing on game-based interventions, including delusions and smoking cessation. He has contributed significantly to the development of smartphone app interventions for addictive disorders and mood regulation. Prof. Khazaal has published extensively on the assessment and psychopathology of addictive disorders. He also leads research on Recovery Oriented Services, exploring community interventions and peer support initiatives. 🌱📱🚭📚

Research Focus

Yasser Khazaal is a researcher primarily focused on behavioral addictions, particularly in the context of online gaming and internet use. His work explores how common behaviors can become problematic without necessarily being pathologized as addiction. He investigates self-reported motivations behind playing online games, such as World of Warcraft, and examines problematic involvement in these games using various psychological and survey methods. Khazaal’s research aims to refine the understanding of behavioral addiction and its implications for mental health, with a particular interest in the validation and adaptation of assessment tools for addictive behaviors in digital environments. 💻🕹️📊

Publication Top notes

Are we overpathologizing everyday life? A tenable blueprint for behavioral addiction research

How can we conceptualize behavioural addiction without pathologizing common behaviours?

Why do you play World of Warcraft? An in-depth exploration of self-reported motivations to play online and in-game behaviours in the virtual world of Azeroth

French validation of the internet addiction test

Validation of a short French version of the UPPS-P Impulsive Behavior Scale

Problematic involvement in online games: A cluster analytic approach

Does self-selection affect samples’ representativeness in online surveys? An investigation in online video game research

Motivations to play specifically predict excessive involvement in massively multiplayer online role-playing games: evidence from an online survey

 

 

 

Karen Allison | Medicine and Health Sciences | Best Researcher Award

Karen Allison | Medicine and Health Sciences | Best Researcher Award

Assoc. Prof. Dr Karen Allison, University of Rochester, United States

Assoc. Prof. Dr. Karen Allison is a dedicated ophthalmologist specializing in glaucoma care 👁️‍🗨️. She holds a Doctor of Medicine from Robert Wood Johnson Medical School (1990) 🎓 and an MBA from George Washington University (2013). Currently at the Flaum Eye Institute, she serves as Glaucoma Service Chief and Fellowship Director 👩‍⚕️. With extensive experience in clinical research and education, Dr. Allison has authored impactful studies on glaucoma, disparities in healthcare, and genetic factors in ocular diseases 📚🧬. Her accolades include Leading Physicians in the World and the Women of Distinction honors 🌟. She’s a passionate advocate for diversity and health equity 💙.

Publication Profile

Orcid

Education

Associate Professor Dr. Karen Allison holds a Doctor of Medicine (M.D.) degree from the University of Medicine and Dentistry of New Jersey (Robert Wood Johnson Medical School), earned in May 1990 🩺📚. Further enhancing her expertise, she pursued a Master of Business Administration (M.B.A.) at The George Washington University in Washington, D.C., graduating in January 2013 🎓💼. With a strong foundation in both medicine and business, Dr. Allison combines her clinical acumen and strategic leadership to excel in academia and healthcare management 🌟🌐. Her interdisciplinary background empowers her to contribute meaningfully to education, research, and organizational development. 🌿📖

Certifications and Professional Experience 

Assoc. Prof. Dr. Karen Allison is a board-certified ophthalmologist with extensive expertise in both private practice and academia. 🌟 Her significant contributions at the Flaum Eye Institute include serving as Glaucoma Fellowship Director and Glaucoma Service Chief, showcasing her leadership and dedication to advancing ophthalmic care. 👁️‍🗨️ With a deep commitment to education and innovation in glaucoma management, she bridges clinical excellence with academic rigor. 📚💡 Dr. Allison’s efforts reflect her unwavering passion for improving patient outcomes and mentoring future ophthalmologists, solidifying her reputation as a respected figure in the field of ophthalmology. 🏥🌿

Editorial Roles and Recognition 

Assoc. Prof. Dr. Karen Allison is a leading figure in ophthalmic research and clinical practice 🌟👁️‍🗨️. Her editorial roles in prestigious journals, including the Cureus Journal of Medical Science and the Journal of Medical Case Reports 📚🖋️, underscore her commitment to advancing the field. Through her peer-reviewed publications in high-impact journals 📰📈, Dr. Allison has made significant contributions to the academic community, fostering innovation and knowledge sharing. Her dedication to excellence in research and clinical care continues to inspire professionals and students alike, driving progress in ophthalmology and beyond 🌐🔬.

Awards and Honors 

Assoc. Prof. Dr. Karen Allison is a distinguished ophthalmologist honored with multiple accolades for her contributions to the field and community. She was featured in the Nationwide Registries Women of Distinction Honors Edition in 2021, and recognized as one of the Leading Physicians in the World in 2013. Dr. Allison was named a Top Ophthalmologist in New York in 2013 and 2014. Her dedication to community service earned her awards from the Lions Club of Brooklyn-Kings County in 2013 and the St. Kitts Organization in 2007. 🌟👩‍⚕️🏅🌍

Research Supervision and Mentorship 

Assoc. Prof. Dr. Karen Allison is dedicated to shaping the next generation of researchers. Her commitment shines through her creation of the glaucoma intern research fellowship, which provides invaluable hands-on experience. Beyond that, she has mentored high school students, medical students, and residents, fostering their growth through guidance and supervision of impactful research. This personalized, nurturing approach to education makes her an exceptional academic mentor, helping students thrive in both clinical and research settings. Her passion for teaching and research mentorship is truly inspiring. 🧑‍🏫🔬👩‍🔬💡📚

Research Focus

Assoc. Prof. Dr. Karen Allison’s research primarily focuses on ocular health disparities, particularly glaucoma and age-related macular degeneration (AMD). Her work examines racial, ethnic, and gender disparities in eye care access and treatment, analyzing patterns in gene expression and clinical outcomes across different populations. She evaluates the impact of socioeconomic factors on the utilization of eye care services, leveraging data from sources like the CDC’s Behavioral Risk Factor Surveillance System. Her studies also delve into the genetic underpinnings of eye diseases, seeking to better understand variations in macular tissues and their role in AMD progression. 👁️📊🧬👩‍🔬

Publication Top Notes